NFKB1 and neoplasm: Interestingly, it has been postulated that alternative functions of RIPK3 [96], such as activation of the NFκB-responsive gene expression, may even be sufficient to confer anti-tumor immunity, independently from whether necroptotic cell death is executed or not [19].